CENTOGENE IP GMBH has a total of 17 patent applications. It decreased the IP activity by 87.0%. Its first patent ever was published in 2012. It filed its patents most often in Australia, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals and measurement are JALAN RAJIV, GUANGZHOU BAIYUNSHAN QIXING PHARMACEUTICAL CO LTD and CANNABICS PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | Israel | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Lukas Jan | 7 |
#2 | Rolfs Arndt | 7 |
#3 | Pews-Davtyan Anahit | 6 |
#4 | Beller Matthias | 5 |
#5 | Cozma Claudia | 5 |
#6 | Beller Mathias | 2 |
#7 | Anahit Pews-Davtyan | 1 |
#8 | Pews Davtyan Anahit | 1 |
#9 | Arndt Rolfs | 1 |
#10 | Claudia Cozma | 1 |
Publication | Filing date | Title |
---|---|---|
EP3446128A1 | Method for the diagnosis of cystic fibrosis | |
EP3236265A1 | Method for the diagnosis of cystic fibrosis | |
AU2012359165A1 | Combination of a compound having the ability to rearrange a lysosomal enzyme and ambroxol and/or a derivative of ambroxol |